- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/86 - HydrazidesThio or imino analogues thereof
Patent holdings for IPC class C07D 213/86
Total number of patents in this class: 54
10-year publication summary
|
6
|
5
|
1
|
4
|
4
|
5
|
0
|
5
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| HMI Medical Innovations, LLC | 14 |
8 |
| The Research Foundation for The State University of New York | 1700 |
4 |
| Synta Pharmaceuticals Corp. | 153 |
3 |
| Theravance Biopharma R&D IP, LLC | 428 |
3 |
| Bayer Cropscience AG | 1897 |
2 |
| University of Florida Research Foundation, Inc. | 4133 |
2 |
| Stc.unm | 667 |
2 |
| London Pharmaceuticals and Research Corporation | 27 |
2 |
| F. Hoffmann-La Roche AG | 7832 |
1 |
| Roche Diagnostics GmbH | 2708 |
1 |
| Roche Diagnostics Operations, Inc. | 1506 |
1 |
| LG Chem, Ltd. | 17805 |
1 |
| The Regents of the University of California | 20473 |
1 |
| Syngenta Crop Protection AG | 6429 |
1 |
| The Johns Hopkins University | 5796 |
1 |
| Astellas Pharma Inc. | 1033 |
1 |
| Eurofarma Laboratorios S.A. | 38 |
1 |
| Fuji Yakuhin Co., Ltd. | 11 |
1 |
| Fundação Oswaldo Cruz - FIOCRUZ | 15 |
1 |
| Monash University | 725 |
1 |
| Other owners | 16 |